Senti Biosciences is trading at $0.30, down 5.52%, with no clear company-specific announcement explaining the decline identified in searches.
- The price is as of 12:02 p.m. ET on October 13, 2026.
- Biotechnology shares are under pressure: supplied sector context reports XBI down 2.01%, and a biotech morning brief also described a sector pullback. This provides context but does not establish a specific cause for Senti Biosciences’ move.